Cognition in people with end-stage kidney disease treated with hemodialysis: a systematic review and meta-analysis

Emma O'Lone*, Michael Connors, Philip Masson, Sunny Wu, Patrick J. Kelly, David Gillespie, Daniel Parker, William Whiteley, Giovanni F. M. Strippoli, Suetonia C. Palmer, Jonathan C. Craig, Angela C. Webster

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    85 Citations (Scopus)

    Abstract

    Background: Cognitive impairment is associated with poorer quality of life, risk for hospitalization, and mortality. Cognitive impairment is common in people with end-stage kidney disease treated with hemodialysis, yet the severity and specific cognitive deficits are uncertain. Study Design: Systematic review and meta-analysis. Setting & Population: Adults receiving hemodialysis compared with the general population, people with non-dialysis-dependent chronic kidney disease (NDD-CKD), people receiving peritoneal dialysis, or people with nondialyzed chronic kidney failure. Selection Criteria for Studies: Randomized controlled trials, cohort or cross-sectional studies without language restriction. Index Tests: Validated neuropsychological tests of cognition. Outcomes: Cognitive test scores, aggregated by cognitive domain: orientation and attention, perception, memory, language, construction and motor performance, concept formation and reasoning, and executive functions. Results: 42 studies of 3,522 participants. Studies were of high or uncertain risk of bias, assessed by the Newcastle-Ottawa Scale. People treated with hemodialysis had worse cognition than the general population, particularly in attention (n = 22; standardized mean difference [SMD], -0.93; 95% CI, -1.18 to -0.68). Hemodialysis patients performed better than nondialyzed patients with chronic kidney failure in attention (n = 6; SMD, 0.70; 95% CI, 0.45 to 0.96) and memory (n = 6; SMD, 0.36; 95% CI, 0.08 to 0.63), but had poorer memory than the general population (n = 16; SMD, -0.41; 95% CI, -0.91 to 0.09) and people with NDD-CKD (n = 5; SMD, -0.40; 95% CI, -0.60 to -0.21). There were insufficient data to show other differences among people receiving hemodialysis and those receiving peritoneal dialysis or with NDD-CKD. Limitations: Potentially biased studies, not wholly adjusted for education. High heterogeneity, mainly due to the large variety of tests used to assess cognition. Conclusions: People treated with hemodialysis have impaired cognitive function compared to the general population, particularly in the domains of orientation and attention and executive function. Cognitive deficits in specific domains should be further explored in this population and should be considered when approaching education and chronic disease management.

    Original languageEnglish
    Pages (from-to)925-935
    Number of pages11
    JournalAmerican Journal of Kidney Diseases
    Volume67
    Issue number6
    DOIs
    Publication statusPublished - 1 Jun 2016

    Keywords

    • cognition
    • hemodialysis
    • end-stage kidney disease (ESKD)
    • renal replacement therapy (RRT)
    • RRT modality
    • neuropsychological tests
    • orientation
    • attention
    • executive function
    • cognitive impairment
    • memory
    • chronic disease management
    • systematic review
    • meta-analysis

    Fingerprint

    Dive into the research topics of 'Cognition in people with end-stage kidney disease treated with hemodialysis: a systematic review and meta-analysis'. Together they form a unique fingerprint.

    Cite this